alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.5370 Nonmeasuring exercise equipment. ( a ) *Identification.* Nonmeasuring exercise equipment consist of devices intended for medical purposes, such as to redevelop muscles or restore motion to joints or for use as an adjunct treatment for obesity. Examples include a prone scooter board, parallel bars, a mechanical treadmill, an exercise table, and a manually propelled exercise bicycle.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 890.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, regarding general requirements concerning records and § 820.198, regarding complaint files.
[48 FR 53047, Nov. 23, 1983, as amended at 66 FR 38818, July 25, 2001]
**Exhibit 32**

 

## **CERTIFICATION**

## ** **

**The undersigned certify pursuant to 18 U.S.C. § 1350, that:**

 

(1)                                The accompanying Quarterly Report on Form10-QSB for the period ended January 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

(2)                                The information contained in the accompanying Reportfairly presents, in all material respects,the financial condition and results of operations of the Company.

 
| Date:  |   March 6, 2006             |   | /s/ Rodney A. Young |   |
|--------|---------------------------------------|--------|---------------------|--------|
|   | Rodney A. Young                       |
|   | President and Chief Executive Officer |
|   |                                  |
|   |                                  |
| Date:  |   March 6, 2006             |   | /s/ Dale H. Johnson |   |
|   | Dale H. Johnson                       |
|   | Chief Financial Officer               |

 

1

----
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.3710 Base metal alloy. ( a ) *Identification.* A base metal alloy is a device composed primarily of base metals, such as nickel, chromium, or cobalt, that is intended for use in fabrication of cast or porcelain-fused-to-metal crown and bridge restorations.
( b ) *Classification.* Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Dental Base Metal Alloys.” The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9. See § 872.1(e) for availability of guidance information.
[69 FR 51766, Aug. 23, 2004]
Editorial Note on Part 570
Editorial Note: Nomenclature changes to part appear at 88 FR 45066, July 14, 2023.

§ 570.210 How to send your GRAS notice to FDA. ( a ) Send your GRAS notice to the Division of Animal Feeds (HFV-220), Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855.
( b ) When you submit your GRAS notice, you may do so either in an electronic format that is accessible for our evaluation or on paper. If you send your GRAS notice on paper, a single paper copy is sufficient.
_________________________________________ 

 

 

Order Michigan Supreme Court

Lansing, Michigan 

December 13, 2006 Clifford W. Taylor,

 Chief Justice 

131992 Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee, 

Robert P. Young, Jr. 

Stephen J. Markman,

 Justices 

v SC: 131992 

 COA: 270667 

Calhoun CC: 01-003474-FH 

NICKOLAS SCOTT KILBOURNE,

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the July 10, 2006 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the questions presented should be reviewed by this Court. 

p1206 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

December 13, 2006 

 Clerk
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2400 Vectorcardiograph. ( a ) *Identification.* A vectorcardiograph is a device used to process the electrical signal transmitted through electrocardiograph electrodes and to produce a visual display of the magnitude and direction of the electrical signal produced by the heart.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1135 C-peptides of proinsulin test system. ( a ) *Identification.* A C-peptides of proinsulin test system is a device intended to measure C-peptides of proinsulin levels in serum, plasma, and urine. Measurements of C-peptides of proinsulin are used in the diagnosis and treatment of patients with abnormal insulin secretion, including diabetes mellitus.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2305, Jan. 14, 2000]
| (logo) NTS NATIONAL

TAX SEARCH, LLC | 130 S. Jefferson, Suite 300

Chicago, IL 60661

312-233-6440 |
|--------------------------------------|--------------------------------------------------------------|

 

 

REPORT ON ASSESSMENT OFCOMPLIANCE WITH APPLICABLE SECURITIES AND EXCHANGE COMMISSION’SREGULATION AB SERVICING CRITERIA

 

 

For the calendar year endingDecember 31, 2016, National Tax Search, LLC has been a Tax Service Vendor for **WellsFargo Bank** (the “Servicer”).

 

National Tax Search, LLC(“NTS”) is responsible for assessing compliance as of December 31,2016 and for the period from January 1, 2016 through December 31, 2016 (the“Reporting Period”) with the servicing criteria set forth in Title17, Section 229.1122(d) of the Code of Federal Regulations (the“CFR”). NTS has used the servicing criteria communicated to NTS bythe Servicer to assess compliance with the applicable servicing criteria. Onlyservicing criteria 1122 (d) (l)(ii), 1122 (d)1(iv), 1122 (d)2(ii), 1122(d)2(v), 1122(d)2(vi), 1122(d)(4)(xi), and 1122(d)(4)(xii) (the“Applicable Servicing Criteria”) are applicable to the activitiesNTS performs with respect to the transactions covered by this report. NTS hasdetermined that the remaining servicing criteria set forth in Item 1122 (d) ofthe SEC Regulation AB are not applicable to the activities it performs withrespect to the transactions covered by this report. The transactions covered bythis report include all tax payments made on behalf of the Servicer usingNTS’s TaxQ system (the “Platform Transactions”).

 

NTS, as a vendor, has assessedits compliance with the Applicable Servicing Criteria for the Reporting Periodand has concluded that NTS has complied, in all material respects, with theApplicable Servicing Criteria as of December 31, 2016 and for the ReportingPeriod with respect to the Platform Transactions taken as a whole.

 

Plante & Moran, PLLC, an independentregistered public accounting firm, has issued an attestation report on theassessment of compliance with the Applicable Servicing Criteria as of December31, 2016 and for the Reporting Period as set forth in this assertion.

 

National Tax Search, LLC, asVendor to Servicer

 

 

/s/ Lori D. Eshoo

Lori D. Eshoo, President/CEO 

January 23, 2017
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 11-1527

RICHARD BLAKE,

 Plaintiff – Appellant,

v.

BURGER KING CORP.,

 Defendant - Appellee.

Appeal from the United States District Court for the Eastern 

District of Virginia, at Richmond. Henry E. Hudson, District 

Judge. (3:10-cv-00675-HEH)

Submitted: August 18, 2011 Decided: August 22, 2011

Before WILKINSON, DAVIS, and KEENAN, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Richard Blake, Appellant Pro Se. Tyler Brown, JACKSON LEWIS, 

LLP, Reston, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Richard Blake appeals the district court’s order 

dismissing his employment discrimination suit. We have reviewed 

the record and find no reversible error. Accordingly, we affirm 

for the reasons stated by the district court. Blake v. Burger 

King Corp., No. 3:10-cv-00675-HEH (E.D. Va. Apr. 18, 2011). We 

dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before the 

court and argument would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule contains summary financial information extracted from
     second quarter Form 10-QSB and is qualified in its entirety by reference
     to such financial statements.
</LEGEND>                     
<MULTIPLIER>                    1
<CURRENCY>                      U.S. Dollars             
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>               SEP-30-1997         
<PERIOD-START>                  OCT-01-1996   
<PERIOD-END>                    MAR-31-1997   
<EXCHANGE-RATE>                           1   
<CASH>                              197,658   
<SECURITIES>                              0   
<RECEIVABLES>                         2,007   
<ALLOWANCES>                              0   
<INVENTORY>                               0   
<CURRENT-ASSETS>                    199,665   
<PP&E>                              404,914   
<DEPRECIATION>                      106,178   
<TOTAL-ASSETS>                      498,401   
<CURRENT-LIABILITIES>                16,291   
<BONDS>                                   0   
<PREFERRED-MANDATORY>                     0   
<PREFERRED>                               0   
<COMMON>                            122,146   
<OTHER-SE>                                0   
<TOTAL-LIABILITY-AND-EQUITY>        498,401   
<SALES>                                   0   
<TOTAL-REVENUES>                     28,200   
<CGS>                                     0   
<TOTAL-COSTS>                         3,819   
<OTHER-EXPENSES>                          0   
<LOSS-PROVISION>                          0   
<INTEREST-EXPENSE>                    1,237   
<INCOME-PRETAX>                      23,144   
<INCOME-TAX>                              0   
<INCOME-CONTINUING>                  23,144   
<DISCONTINUED>                        6,769   
<EXTRAORDINARY>                           0   
<CHANGES>                                 0   
<NET-INCOME>                         16,375   
<EPS-PRIMARY>                           .00   
<EPS-DILUTED>                           .00   
        

</TABLE>
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.9 Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act). The exemption from the requirement of premarket notification (section 510(k) of the act) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the device would not be associated with high morbidity or mortality. Accordingly, manufacturers of any commercially distributed class I or II device for which FDA has granted an exemption from the requirement of premarket notification must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce for commercial distribution the device when: ( a ) The device is intended for a use different from the intended use of a legally marketed device in that generic type of device; e.g., the device is intended for a different medical purpose, or the device is intended for lay use where the former intended use was by health care professionals only;
( b ) The modified device operates using a different fundamental scientific technology than a legally marketed device in that generic type of device; e.g., a surgical instrument cuts tissue with a laser beam rather than with a sharpened metal blade, or an in vitro diagnostic device detects or identifies infectious agents by using deoxyribonucleic acid (DNA) probe or nucleic acid hybridization technology rather than culture or immunoassay technology; or
( c ) The device is an in vitro device that is intended: ( 1 ) For use in the diagnosis, monitoring, or screening of neoplastic diseases with the exception of immunohistochemical devices;
( 2 ) For use in screening or diagnosis of familial or acquired genetic disorders, including inborn errors of metabolism;
( 3 ) For measuring an analyte that serves as a surrogate marker for screening, diagnosis, or monitoring life-threatening diseases such as acquired immune deficiency syndrome (AIDS), chronic or active hepatitis, tuberculosis, or myocardial infarction or to monitor therapy;
( 4 ) For assessing the risk of cardiovascular diseases;
( 5 ) For use in diabetes management;
( 6 ) For identifying or inferring the identity of a microorganism directly from clinical material;
( 7 ) For detection of antibodies to microorganisms other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used to determine immunity, or the assay is intended for use in matrices other than serum or plasma;
( 8 ) For noninvasive testing as defined in § 812.3(k) of this chapter; and
( 9 ) For near patient testing (point of care).
[65 FR 2321, Jan. 14, 2000]
```

[Federal Register Volume 77, Number 70 (Wednesday, April 11, 2012)]
[Notices]
[Pages 21834-21835]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8653]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Airborne Radar Altimeter Equipment (For Air Carrier Aircraft)

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Cancellation of Technical Standard Order (TSO)-C67, Airborne 
Radar Altimeter Equipment (For Air Carrier Aircraft).

-----------------------------------------------------------------------

SUMMARY: This is a confirmation notice of the cancellation of TSO-C67, 
Airborne Radar Altimeter Equipment (For Air Carrier Aircraft). The 
effect of the cancelled TSO will result in no new TSO-C67 design or 
production approvals. However, cancellation will not affect any current 
production of an existing TSO authorization (TSOA). Articles produced 
under an existing TSOA can still be installed per the existing 
airworthiness approvals, and all applications for new airworthiness 
approvals will still be processed.

SUPPLEMENTARY INFORMATION: 

Background

    On November 15, 1960, the FAA published TSO-C67, Airborne Radar 
Altimeter Equipment (for air carrier aircraft). Since 1978, there have 
been no new applications for TSOA for TSO-C67. Our research indicates 
there are no authorized manufacturers currently

[[Page 21835]]

manufacturing, advertising, or selling TSO-C67 compliant equipment. 
Therefore, given the obsolescence of the equipment, and the lack of 
industry interest in TSO-C67 product designs, we proposed cancelling 
TSO-C67. Please note that TSO-C87, Airborne Low Range Radio Altimeter, 
is currently used for Radio Altimeter certification and is not affected 
by this action.

Comments

    There were no comments received during the public comment period of 
the Federal Register Notice of the FAA's intent to cancel TSO-C67.

Conclusion

    TSO-C67 is cancelled effective September 30, 2012. Please note that 
TSO-C87, Airborne Low Range Radio Altimeter, is currently used for 
Radio Altimeter certification and is not affected by this action.

    Issued in Washington, DC, on April 6, 2012.
Susan J.M. Cabler,
Assistant Manager, Aircraft Engineering Division, Aircraft 
Certification Service.
[FR Doc. 2012-8653 Filed 4-10-12; 8:45 am]
BILLING CODE 4910-13-P
```
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6992 Medical washer-disinfector. ( a ) *Identification.* A medical washer-disinfector is a device that is intended for general medical purposes to clean, decontaminate, disinfect, and dry surgical instruments, anesthesia equipment, hollowware, and other medical devices.
( b ) *Classification.* Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Medical Washers and Medical Washer-Disinfectors.” ( 1 ) Medical washer-disinfectors that are intended to clean, high level disinfect, and dry surgical instruments, anesthesia equipment, hollowware, and other medical devices.
( 2 ) Medical washer-disinfectors that are intended to clean, low or intermediate level disinfect, and dry surgical instruments, anesthesia equipment, hollowware, and other medical devices are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 880.9.
[67 FR 69121, Nov. 15, 2002]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.4010 General purpose reagent. ( a ) A general purpose reagent is a chemical reagent that has general laboratory application, that is used to collect, prepare, and examine specimens from the human body for diagnostic purposes, and that is not labeled or otherwise intended for a specific diagnostic application. It may be either an individual substance, or multiple substances reformulated, which, when combined with or used in conjunction with an appropriate analyte specific reagent (ASR) and other general purpose reagents, is part of a diagnostic test procedure or system constituting a finished in vitro diagnostic (IVD) test. General purpose reagents are appropriate for combining with one or more than one ASR in producing such systems and include labware or disposable constituents of tests; but they do not include laboratory machinery, automated or powered systems. General purpose reagents include cytological preservatives, decalcifying reagents, fixative and adhesives, tissue processing reagents, isotonic solutions and pH buffers. Reagents used in tests for more than one individual chemical substance or ligand are general purpose reagents (e.g., *Thermus aquaticus* (TAQ) polymerase, substrates for enzyme immunoassay (EIA)).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9. If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[45 FR 60592, Sept. 12, 1980, as amended at 54 FR 25045, June 12, 1989; 62 FR 62260, Nov. 21, 1997; 66 FR 38789, July 25, 2001]
§ 876.4300 Endoscopic electrosurgical unit and accessories. ( a ) *Identification.* An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.
( b ) *Classification.* Class II (performance standards).
# U ni te d S ta te s Co ur t of A pp ea ls For the Eig hth Circu it

__ __ __ __ __ __ __ __ __ __ __ __ __ _
No. 1 8- 21 77

__ __ __ __ __ __ __ __ __ __ __ __ __ _ Uni te d S ta te s o f Am eri ca

ll ll ll ll ll ll ll ll ll ll l Pla in ti

ff - App el le e

v.

Alb ert o C ol in a, Jr

.
ll ll ll ll ll ll ll ll ll ll l Defe nd

an t - Ap pe ll an t

__ __ __ __ __ __ App eal fro m

Uni te d S ta te s Di st ric t Co ur t fo r th e Weste rn Dis tri ct of M is so ur i - Sp rin gf ie ld

__ __ __ __ __ __
Su bm it te d: Jan ua ry

4, 2 01 9 Fi le d: Jan ua ry

9, 2 01 9 [Un pu bl is he d]

__ __ __ __ __ __ Befo re GRUENDER, W OLLMAN, and ERICKSON, Ci rcu it Ju dg es

.

__ __ __ __ __ __

PER CURI AM.

Alb ert o Co li na di rect ly ap pe al s aft er he pl ead ed gu il ty to two fir earm ch arg es

an d th e di st ric t co ur t 1 se nt en ced hi m to two co ns ecu ti ve st at ut or y -m ax im um pri so n

1 The Hon or a b le Ro se an n A. Ketc hm ark
, Uni te d St at es Dis tri ct Ju dg e fo r th e W es te rn Dis tri ct of M is so ur i.te rm s, whi ch res ul te d in a to ta l am ou nt of pr is on ti m e wit hi n hi s G u i de li ne s ran ge

.

His co un se l ha s m ov ed for lea ve to wit hd raw, an d h as fil ed a br ie f un de r And ers v. Cal ifo rn ia
, 3 8 6 U.S. 73 8 (1 96 7)
, es se nt ia ll y ch al le ng in g th e reas on ab le ne ss of Co li na ’s sen te nc e, in cl ud in g t he im po si ti on of c on se cu ti ve pri so n t erm s.

Upo n care fu l rev ie w , w e co nc lu de th at th e di st ric t co ur t di d no t im po se an

un reas on ab le am ou nt of pr is on ti m e. See Uni te d Sta te s v. Feem st er , 5 72 F.3 d 45 5, 46 1- 62 (8 th Ci r. 20 09 ) (en ba nc ) (s en te nc es are rev ie wed un de r de fere nt ia l ab us e-o fdi sc ret io n st an da rd ; di sc us si ng su bs ta nt iv e reas on ab le ne ss ); se e al so Uni te d St at es v. Cal l a way , 76 2 F.3 d 75 4, 76 0 (8 th Ci r. 20 14 ) (o n ap pe al
, wit hi n- Gui de li ne s- ran ge

se nt en ce m ay be pr es um ed reas on ab le ); Uni te d St at es v. W oh lm an , 65 1 F.3 d 87 8, 88 7 (8 th Ci r. 20 11 ) (co ur t ne ed no t m ech a n i c al ly reci te 18 U.S.C. § 35 53 (a) fact or s, so l o n g a s it is cl ear fro m reco rd th at co ur t act ua ll y co ns id ered th em in de te rm in in g

se nt en ce). W e fu rth er con cl ud e th at it was no t un reas on ab le fo r th e di st ric t co ur t to im po se co ns ecu ti ve pr is on te rm s. See 18 U.S.C. § 35 84 (a) (if m ul ti pl e t e r m s of im pr is on m en t are im

po se d on de fen da nt at th e sa m e ti m e, te rm s m ay ru n co nc ur ren tl y

or co ns ecu ti ve ly ; i n d e t erm in in g whe th er te rm s im po se d are to be or de red to ru n

co nc ur ren tl y

or c on se cu ti ve ly, co ur t s ha ll co ns id er § 35 53 (a) fa ct or s)

.

Fi na ll y , ha vi ng in de pe nd en tl y rev ie wed th e reco rd un de r Pen so n v. Ohi o , 48 8 U.S. 75 (1 98 8) , we fin d no no n- fri vo lo us is su es fo r ap p e a l

. A c co rd in gl y , we gr an t

co un se l l eav e to wit hd raw, an d we a ffi rm

.

__ __ __ __ __ __ __ __ __ __ __ __ __ __ __

-2

-
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.1880 Wall-mounted radiographic cassette holder. ( a ) *Identification.* A wall-mounted radiographic cassette holder is a device that is a support intended to hold and position radiographic cassettes for a radiographic exposure for medical use.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 892.9.
[53 FR 1567, Jan. 20, 1988, as amended at 61 FR 1125, Jan. 16, 1996; 66 FR 38819, July 25, 2001]